<p>James Beeson and Damien Drew of the Burnet Institute in Australia propose to generate chimeric Plasmodium falciparum that expresses the antigens of another malaria parasite, P. vivax, allowing them to be evaluated as vaccine candidates. Because laboratory culturing of P. vivax is costly and technically difficult, this new method could help accelerate the development of vaccines against malaria caused by P. vivax.</p>


James Beeson and Damien Drew of the Burnet Institute in Australia propose to generate chimeric Plasmodium falciparum that expresses the antigens of another malaria parasite, P. vivax, allowing them to be evaluated as vaccine candidates. Because laboratory culturing of P. vivax is costly and technically difficult, this new method could help accelerate the development of vaccines against malaria caused by P. vivax.